Covid-19 race for cure: Drugs on trial

Drug companies and research organisations seeking a Covid-19 cure are turning to old molecules that are either out of production or those on which development work stopped due to lack of commercial viability.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2UIAqBT
via IFTTT